GLP-1 Weight Loss Programs Compared: Gala vs Viviomd vs TrimRX (2026)

Bottom line: GLP-1 medications produce 15–22% body weight loss at 12 months — the highest documented results of any weight loss method. Compounded versions cost $179–$225/month through telehealth platforms, versus $1,000+ for brand-name Ozempic without insurance.

Not sure which program fits your budget and situation? Our GLP-1 program matching quiz routes you to the best-fit platform in 3 minutes based on your budget, administration preference, and medical history. Or use the GLP-1 cost calculator to see the exact 12-month cost difference between brand-name and compounded options. Full eligibility details and what to expect in the first 30 days are covered in our GLP-1 eligibility guide.

---

What is a GLP-1 medication? GLP-1 (glucagon-like peptide-1) receptor agonists — including Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) — are injectable hormones that slow gastric emptying and signal the brain to reduce hunger. The result: sustained calorie reduction without willpower. Clinical trials show 15–22% average body weight loss at 12 months — 3–5x the results of diet-only approaches. Since 2023, telehealth platforms have made compounded versions (same active ingredient, made by licensed US pharmacies) available for under $300/month — and some as low as $179.

We compared the four most accessible platforms currently offering compounded GLP-1 medications.

1. Gala — $179/Month for All Doses, Including Physician Consultation

Price: $179/month for all dosages, including physician consultation

Gala is a direct-to-consumer telehealth platform providing compounded Tirzepatide — the same active ingredient as Mounjaro. At $179/month covering all dosages and the physician consultation, Gala is currently the most competitive GLP-1 price available in the US market. Brand-name Mounjaro runs $900–$1,200/month without insurance.

Best for: Adults with BMI 30+ (or BMI 27+ with a weight-related condition) who want medically supervised weight loss without paying brand-name prices.

• Check Gala Eligibility →

---

2. Viviomd — The Only Major GLP-1 Platform With a Needle-Free Oral Tablet Format

Format: Oral Disintegrating Tablet (ODT) — no injections required

Viviomd connects patients with licensed providers for GLP-1 treatments in Oral Disintegrating Tablet form. The ODT dissolves under your tongue — no syringes, no self-injection. This is the only major telehealth GLP-1 platform currently offering a needle-free format. Founded 2024, Delaware-based.

• Best for: Adults 25–60 who want medically supervised weight loss without injectable medications
• See Viviomd Eligibility →

---

3. TrimRX — 3-Minute Assessment, Physician Review Within 24 Hours

Assessment: 3 minutes — fastest intake process of any platform we tested

TrimRX provides medically supervised access to Semaglutide and Tirzepatide via a 3-minute online assessment. Physician review is completed within 24 hours. Designed for US adults who want to start quickly without a long intake process.

• Best for: US adults 25–65 seeking immediate access without lengthy enrollment forms
• Start TrimRX Assessment →

---

4. ShedRX — Free Telehealth Consultation Before Any Commitment

Free initial telehealth consultation — no upfront commitment required

ShedRX offers a free telehealth consultation for weight loss injections including Semaglutide and Tirzepatide. Personalized plans include health coaching and ongoing physician support. Best option if you want to speak with a provider and understand your options before committing to a monthly plan.

• Best for: Patients who want a provider conversation before starting a GLP-1 program
• Start Free ShedRX Consultation →

---

GLP-1 Clinical Data: 15–22% Body Weight Loss at 12 Months, vs 5–8% for Diet Programs

• 15–22% body weight lost at 12 months in SURMOUNT-1 (Tirzepatide) clinical trials (New England Journal of Medicine, 2022)
• 5–8% typical result from behavioral diet-only interventions at 6 months (Journal of the Academy of Nutrition and Dietetics meta-analysis)
• $179–$225/month cost range for compounded telehealth GLP-1 programs vs $900–$1,200 for brand-name monthly supply

You Qualify if Your BMI Is 30+ (or 27+ With a Weight-Related Condition) and No Contraindications

Most telehealth GLP-1 providers require:

• BMI 30+ (or BMI 27+ with a weight-related condition such as hypertension or type 2 diabetes)
• No history of: Type 1 diabetes, pancreatitis, active cancer, eating disorders, MTC/MEN2
• Not pregnant or breastfeeding
• US residency and age 18+

Lowest Price: Gala. No Needles: Viviomd. Fastest Start: TrimRX.

For the lowest price, Gala at $179/month is the current market leader. For patients who want no needles, Viviomd’s ODT format is the only oral option. For fastest enrollment, TrimRX’s 3-minute assessment is the most streamlined.

The clinical evidence gap between GLP-1 medication and diet-only weight loss is now very large. For adults with significant weight to lose and no contraindications, speaking with a telehealth provider is worth the 3–5 minutes of intake.

What is the cheapest GLP-1 weight loss program available in 2026?

Gala offers compounded Tirzepatide at $179/month including all dosages and physician consultation — the lowest current price in the US telehealth market. TrimRX and Viviomd are comparable at $179–$225/month. Brand-name Ozempic runs $900–$1,200/month without insurance. All require BMI 30+ or BMI 27+ with a qualifying condition.

---

This article contains affiliate links. Verto earns a commission when you purchase through these links at no extra cost to you. Individual results vary. Consult your physician before starting any prescription medication.